S100B and central nervous system cancer: Furthermore, previous studies have reported that risperidone increased S100B secretion from C6 glioma cells after 1-h treatment (de Souza et al., 2013) and increased S100B expression of primary cultured astrocytes after 24-h treatment (Nardin et al., 2011).